increase in cGMP levels via particulate guanylyl cyclase.
synthase (eNOS). Stimulation of soluble guanylyl cyclase This mechanism is apparent when cAMP has been raised was essential for cholinergic inhibition of L-type calcium by inhibition of phosphodiesterase. The role of the cGMP current (I ) following adrenergic pre-stimulation, alCaL pathway in the cholinergic modulation of cardiac exthough others fail to confirm this result (e.g. Refs.
[2,8,9]). NO generated by neuronal nitric oxide synthase (nNOS) increase the release of H-acetylcholine to field stimulation (A) and the heart rate response to vagal nerve stimulation (B). This is thought to be due to stimulation of the particulate guanylyl cyclase coupled natriuretic peptide receptor (pGC / NPR) and soluble guanylyl cyclase respectively. Both increase cGMP which may inhibit phosphodiesterase 3 (PDE3) to increaase cAMP-protein kinase A (PKA) dependent phosphorylation of N-type calcium channels (I ) (adapted from [6] cGMP pathway may not be as important as first proposed. cyclase has no role in the cholinergic modulation of stimulation is also coupled to particulate guanylyl cyclase activity [7] must, therefore, be viewed with caution. The functional role of cGMP in the cholinergic control of cardiac excitability is clearly site specific.
